Level 2

Company Announcements

Lloyds and Day Lewis Pharmacy listings

RNS Number : 7733F
TyraTech, Inc.
25 February 2015
 

25 February 2015

 

TyraTech, Inc.

("TyraTech" or the "Company")

 

Lloyds and Day Lewis Pharmacy listings

 

Vamousse® Advertising and Marketing Award

 

TyraTech, Inc. (AIM: TYR and TYRU), a life sciences company focused on nature-derived insect and parasite control products, is delighted to announce new listings for its Vamousse® Head Lice Treatment and Protective products with Lloyds Pharmacy and its Treatment product with Day Lewis Pharmacy in the UK.

 

Day Lewis, which began stocking the Vamousse range in January 2015, is the largest independent pharmacy chain in the UK with more than 200 outlets. Lloyds, a well respected household name at the forefront of community pharmacy, has a distribution network of more than 1600 outlets in the UK and is expected to commence stocking Vamousse products from March 2015.  

 

Vamousse - broadening the distribution network

With distribution already established in Boots, Superdrug, Sainsbury's, Tesco and Rowlands, the addition of Lloyds and Day Lewis gives Vamousse a comprehensive UK distribution platform for 2015. Increasing the physical distribution points is particularly important for head lice products that tend to be emergency purchases. Customers need to be able to find the products close to home in order to solve their head lice problems as fast as possible.  

 

Vamousse - advertising and marketing campaign award

TyraTech is particularly pleased that the Vamousse brand has won the Independent Community Pharmacy (ICP) magazine 'Pharmacy Product Of The Year - Best Advertising Campaign' award. This prestigious award is voted for by practicing pharmacists. The award recognises and reflects the strong awareness and engagement generated by the Vamousse marketing campaign amongst pharmacists and pharmacy staff.  Their awareness and recommendation of the Vamousse Treatment and Protective range are key ingredients in the commercial success of these products.

 

Bruno Jactel CEO of TyraTech commented:

"We are delighted to announce these new listings for our Vamousse treatment and preventative products, taking us initially into more than 1300 new distribution points in the UK from March 2015.

 

"I am very pleased with our achievements in the UK marketplace in the eight months since the launch of the Vamousse product range. We are confident of continued positive developments as our comprehensive UK distribution platform reaps the benefits of our highly engaging and effective marketing campaign."

 

For further information please contact:

TyraTech, Inc.
Bruno Jactel, Chief Executive Officer

Vincent Morgus, Chief Financial Officer and Treasurer


Tel: +1 919 415 4340

Tel: +1 919 415 4287

SPARK Advisory Partners Limited, Nominated Adviser
Matt Davis / Mark Brady


  Tel: +44 20 3368 3550

Allenby Capital Limited, Joint Broker
Chris Crawford


Tel: +44 20 3328 5656

Whitman Howard Limited, Joint Broker
Ranald McGregor-Smith / Niall Devins

               
         Tel: +44 20 7087 4555

Walbrook, Financial PR and IR
Nick Rome/ Guy McDougall


Tel: +44 20 7933 8780

 

 

 

 



 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPKQDQOBKDNBB

Top of Page